UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060016
Receipt number R000068206
Scientific Title Prospective multicenter cohort study of the clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP)-related procedures
Date of disclosure of the study information 2025/12/08
Last modified on 2025/12/09 06:13:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP)

Acronym

Research on ERCP

Scientific Title

Prospective multicenter cohort study of the clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP)-related procedures

Scientific Title:Acronym

Prospective multicenter cohort study of ERCP-related procedures

Region

Japan


Condition

Condition

Pancreatobiliary diseases

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Adult
Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the clinical outcomes of ERCP-related procedures and their prognostic factors.

Basic objectives2

Others

Basic objectives -Others

Patient factors include patient status (e.g., age, sex, vital signs, past medical history, family history, lifestyle factors, and comorbidities), blood tests, and imaging studies (e.g., radiology reports and imaging files) before and after ERCP, as well as ERCP-related procedures.

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Short- and long-term outcomes of ERCP-related procedures and others

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who undergo ERCP for diagnostic and therapeutic indications

Key exclusion criteria

Patients with missing data on the main exposure variable of a given analysis and those who refused to participate in this research

Target sample size

8000


Research contact person

Name of lead principal investigator

1st name Takeo
Middle name
Last name Watanabe

Organization

The Fraternity Memorial Hospital

Division name

Department of Gastroenterology

Zip code

130-8587

Address

2-1-11 Yokoami, Sumida City, Tokyo, Japan

TEL

0570-200-678

Email

t_watanabe@douai.jp


Public contact

Name of contact person

1st name Takeo
Middle name
Last name Watanabe

Organization

The Fraternity Memorial Hospital

Division name

Department of Gastroenterology

Zip code

130-8587

Address

2-1-11 Yokoami, Sumida City, Tokyo, Japan

TEL

0570-200-678

Homepage URL


Email

t_watanabe@douai.jp


Sponsor or person

Institute

The Fraternity Memorial Hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Fraternity Memorial Hospital

Address

2-1-11 Yokoami, Sumida City, Tokyo, Japan

Tel

0570-200-678

Email

mail@douai.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本赤十字社医療センター(東京都)、関東中央病院(東京都)


Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 12 Month 04 Day

Date of IRB

2025 Year 12 Month 05 Day

Anticipated trial start date

2025 Year 12 Month 05 Day

Last follow-up date

2030 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study will use follow-up data obtained during routine clinical care for patients after ERCP-related procedures.


Management information

Registered date

2025 Year 12 Month 08 Day

Last modified on

2025 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068206